Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.
about
Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomasProgress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology GroupWhat we have learned: the impact of quality from a clinical trials perspectiveThe surgical management of paediatric bladder and prostate rhabdomyosarcomaPatterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma CommitteeAccelerated or hyperfractionated radiotherapy for esophageal carcinoma: a meta-analysis of randomized controlled trialsLocal failure in parameningeal rhabdomyosarcoma correlates with poor response to induction chemotherapy.18-Year-Old Woman with an Embryonal Rhabdomyosarcoma of the Uterus in Statu Nascendi.Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma.Prognostic significance of tumor response at the end of therapy in group III rhabdomyosarcoma: a report from the children's oncology group.Pediatric soft tissue sarcomas.Local therapy for rhabdomyosarcoma of the hands and feet: is amputation necessary? A report from the Children's Oncology Group.Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology GroupPhyseal bystander effects in rhabdomyosarcoma radiotherapy: experiments in a new xenograft model.Impact of tumor viability at second-look procedures performed before completing treatment on the Intergroup Rhabdomyosarcoma Study Group protocol IRS-IV, 1991-1997: a report from the children's oncology group.Treatment modalities of bladder/prostate rhabdomyosarcoma: a review.Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.Proton radiotherapy for parameningeal rhabdomyosarcoma: clinical outcomes and late effects.The effect of radiation timing on patients with high-risk features of parameningeal rhabdomyosarcoma: an analysis of IRS-IV and D9803.Intensity Modulated Radiotherapy (IMRT) and Fractionated Stereotactic Radiotherapy (FSRT) for children with head-and-neck-rhabdomyosarcomaThe impact of surgical excision in chest wall rhabdomyosarcoma: a report from the Children's Oncology Group.Proton beam therapy for a patient with large rhabdomyosarcoma of the body trunkRole of surgery in the management of soft tissue tumors.Role of lymphoscintigraphy and sentinel lymph node biopsy in the management of pediatric melanoma and sarcoma.Prognostic Factors for Outcome in Localized Extremity Rhabdomyosarcoma. Pooled Analysis from Four International Cooperative Groups.The crucial role of tumour specimen handling in childhood cancer outcomesRadiation for bone metastases in Ewing sarcoma and rhabdomyosarcoma.Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups.Outcome of patients with localized orbital sarcoma who relapsed following treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-III and -IV, 1984-1997: a report from the Children's Oncology GroupLocal Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology GroupComparison of anticipated and actual control group outcomes in randomised trials in paediatric oncology provides evidence that historically controlled studies are biased in favour of the novel treatment.Intensity-modulated radiation therapy with dose-painting for pediatric sarcomas with pulmonary metastases.Detection of FOXO1 break-apart status by fluorescence in situ hybridization in atypical alveolar rhabdomyosarcoma.45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.Spindle cell embryonal rhabdomyosarcoma of the prostate in an adult patient - case report and review of clinicopathological features.Radiotherapy is Important for Local Control at Primary and Metastatic Sites in Pediatric Rhabdomyosarcoma.Outcomes in Adult Sinonasal Rhabdomyosarcoma.Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patients.Pleomorphic rhabdomyosarcoma infiltrating thoracic spine in a 59-year-old female patient: Case reportResults of RS-99 protocol for childhood solid tumors.
P2860
Q24234049-12F983A1-9DCA-4794-AD71-2E637C2AC910Q24657000-08858B16-2E1E-45B1-A140-58A7E6EECA4CQ27008209-C738664A-5A43-4FEE-A166-31A3FB6D9FACQ27015190-52741DDC-5607-4740-8950-10BDF3CE8A10Q33396263-82DC3379-2FFB-41A2-9420-5F7E1372944EQ33813067-858A3313-9589-456D-BD80-2BF5BEEE7D71Q33821612-262409F9-DAC1-4D6A-89CA-C195BEC0CC44Q34209167-0458A8F4-9763-4337-8C26-86A73BFF0980Q34484192-D3295E57-F25A-483D-8840-1E6DC0CAD192Q34490071-8898250C-CAC7-4192-9252-C9DDCF972D46Q34754962-AFB2D3B4-89FA-429D-86A7-02E20D96F81FQ34786004-0040E811-DB03-49D0-BA33-D1ABC0EAC28BQ34879284-BD8E644D-0E57-4A88-82FD-027A87AA2AF6Q34929490-77FC15BB-B769-42DC-9369-D2F6C663F079Q35084188-124A1A14-048E-4B44-9BA4-32D8BDB06151Q35154422-E87FE671-1214-4A47-919B-BF397BEE8D79Q35760674-CB0785D9-D8DB-4283-AC36-2239330DB6C2Q35792061-975D7933-855A-4608-A226-936D70BEF353Q35914632-39BE8F03-B8CA-4166-8A76-23191BEC0695Q36141759-656A3235-5597-4A67-8AF2-DACB2D65F13BQ36283032-169756CD-5E3D-45FE-8B0E-B58DC504F18EQ36286991-C467B5D3-B864-429D-9BF9-29766F8305C0Q36616534-CFF39468-1DC8-4999-89F6-5E5BB903F6CEQ36717715-735C7EB4-1FD7-48AA-99D1-2CFD655D25CFQ37212341-105AD8D8-965D-4415-9C18-F13CFA88FBB2Q37294008-2E6585D2-02D6-4F67-907E-898AD3D77534Q37301399-CA6DE771-9CC7-4132-954A-E37F6A1FA538Q37404111-823E584A-5D31-4494-8D8F-FDF0B050BCFAQ37478437-4721CF3E-B17C-4811-8381-6F5B9ABB0FE1Q37489203-95B7C7F3-B07D-4F37-9268-DDBC7C5B1E83Q38285777-903D09DE-A9E4-44F0-9BB4-CDCDADCCC040Q38425869-B6BA7888-422D-436B-A6E4-B22B19ABB5B2Q38711061-EFC3ABD0-C213-451A-8C6A-77D5FB23BC32Q38761564-41084571-312A-437D-AD85-38C5110105DEQ38881176-46023DC5-11F5-4A77-A269-830C7A2EAC49Q38925912-258F9B91-3C51-48B4-8852-6432FF3ABA8CQ39409488-EACF8705-C09E-4D68-AD1D-1AB7336A63A7Q40659809-DA5B8261-297F-4331-AD00-AC970012A51AQ41111792-C7853D8F-CEAE-46FD-A612-72C3F46A4FD2Q43167749-9CF1F7D9-2204-4F77-A6D4-90B4D3F6DF5A
P2860
Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Results from the IRS-IV random ...... rcoma--a report from the IRSG.
@ast
Results from the IRS-IV random ...... rcoma--a report from the IRSG.
@en
Results from the IRS-IV random ...... rcoma--a report from the IRSG.
@nl
type
label
Results from the IRS-IV random ...... rcoma--a report from the IRSG.
@ast
Results from the IRS-IV random ...... rcoma--a report from the IRSG.
@en
Results from the IRS-IV random ...... rcoma--a report from the IRSG.
@nl
prefLabel
Results from the IRS-IV random ...... rcoma--a report from the IRSG.
@ast
Results from the IRS-IV random ...... rcoma--a report from the IRSG.
@en
Results from the IRS-IV random ...... rcoma--a report from the IRSG.
@nl
P2093
P1476
Results from the IRS-IV random ...... rcoma--a report from the IRSG.
@en
P2093
Children's Oncology Group Soft ...... uality Assurance Review Center
J C Breneman
S J Qualman
S S Donaldson
P304
P356
10.1016/S0360-3016(01)01709-6
P407
P577
2001-11-01T00:00:00Z